US Patent 9481703 HCV polymerase inhibitors
Patent 9481703 was granted and assigned to Medivir on November, 2016 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
February 27, 2015
Date of Patent
November 1, 2016
Patent Applicant
Patent Application Number
14634449
Patent Citations Received
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 9481703 HCV polymerase inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
